Impedimed Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -1.034x

Impedimed Ltd cash flow conversion efficiency. Based on the latest financial reports, Impedimed Ltd (IPD) has a cash flow conversion efficiency ratio of -1.034x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-10.53 Million ≈ $-7.45 Million USD) by net assets (AU$10.19 Million ≈ $7.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Impedimed Ltd (2008–2026)

Cash flow conversion efficiency of Impedimed Ltd from 2008 to 2026. This chart illustrates how Impedimed Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View IPD stock price for real-time trading data and today's change.

Impedimed Ltd Cash Flow Conversion Ratio Explained

Impedimed Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Impedimed Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Impedimed Ltd ranked by their cash flow conversion efficiency. Also see Impedimed Ltd (IPD) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
General Environmental Conservation Public Company Limited
BK:GENCO
0.019x
Sheffield Resources Ltd
AU:SFX
-0.013x
CodeLab Capital A/S
OL:CODE
-0.370x
Lithium Plus Minerals Ltd
AU:LPM
-0.036x
Modernland Realty Ltd Tbk
JK:MDLN
0.000x
NowVertical Group Inc
V:NOW
1.448x
SAG Holdings Limited
NASDAQ:SAG
0.065x
RPCG PCL -NVDR- BA 1
F:W8M1
N/A

Annual Cash Flow Conversion Efficiency for Impedimed Ltd (2008–2026)

The table below shows the annual cash flow conversion efficiency of Impedimed Ltd from 2008 to 2026. Review IPD free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-06-30 AU$10.19 Million
≈ $7.21 Million
AU$-20.03 Million
≈ $-14.17 Million
-1.966x -175.19%
2025-06-30 AU$20.50 Million
≈ $14.50 Million
AU$-14.64 Million
≈ $-10.36 Million
-0.715x -63.65%
2024-06-30 AU$40.74 Million
≈ $28.83 Million
AU$-17.79 Million
≈ $-12.59 Million
-0.437x -47.27%
2023-06-30 AU$60.88 Million
≈ $43.08 Million
AU$-18.05 Million
≈ $-12.77 Million
-0.296x +3.39%
2022-06-30 AU$51.04 Million
≈ $36.12 Million
AU$-15.66 Million
≈ $-11.08 Million
-0.307x +40.94%
2021-06-30 AU$25.51 Million
≈ $18.05 Million
AU$-13.26 Million
≈ $-9.38 Million
-0.520x +26.02%
2020-06-30 AU$27.36 Million
≈ $19.36 Million
AU$-19.22 Million
≈ $-13.60 Million
-0.702x +43.40%
2019-06-30 AU$15.79 Million
≈ $11.17 Million
AU$-19.59 Million
≈ $-13.86 Million
-1.241x -89.40%
2018-06-30 AU$35.80 Million
≈ $25.33 Million
AU$-23.46 Million
≈ $-16.60 Million
-0.655x -50.68%
2017-06-30 AU$58.80 Million
≈ $41.60 Million
AU$-25.57 Million
≈ $-18.09 Million
-0.435x -65.33%
2016-06-30 AU$85.25 Million
≈ $60.32 Million
AU$-22.42 Million
≈ $-15.86 Million
-0.263x +14.83%
2015-06-30 AU$34.84 Million
≈ $24.65 Million
AU$-10.76 Million
≈ $-7.61 Million
-0.309x +38.57%
2014-06-30 AU$13.53 Million
≈ $9.57 Million
AU$-6.80 Million
≈ $-4.81 Million
-0.503x +30.62%
2013-06-30 AU$10.59 Million
≈ $7.50 Million
AU$-7.67 Million
≈ $-5.43 Million
-0.724x -6.30%
2012-06-30 AU$17.31 Million
≈ $12.25 Million
AU$-11.80 Million
≈ $-8.35 Million
-0.682x -24.75%
2011-06-30 AU$20.68 Million
≈ $14.63 Million
AU$-11.30 Million
≈ $-7.99 Million
-0.546x -16.93%
2010-06-30 AU$22.23 Million
≈ $15.73 Million
AU$-10.39 Million
≈ $-7.35 Million
-0.467x +60.09%
2009-06-30 AU$10.07 Million
≈ $7.12 Million
AU$-11.79 Million
≈ $-8.34 Million
-1.171x -94.18%
2008-06-30 AU$12.30 Million
≈ $8.70 Million
AU$-7.42 Million
≈ $-5.25 Million
-0.603x --

About Impedimed Ltd

AU:IPD Australia Medical Devices
Market Cap
$10.37 Million
AU$14.65 Million AUD
Market Cap Rank
#26837 Global
#1235 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.04
All Time High
AU$1.68
About

ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally. The company offers SOZO Digital Health Platform which transforms fluid status and tissue composition into insights with a single scan; L-Dex Analysis for Lymphedema, designed fo… Read more